Roche ' s Tecentriq Fails Trial in Form of Urothelial Cancer Roche ' s Tecentriq Fails Trial in Form of Urothelial Cancer
Roche ' s immunotherapy Tecentriq failed a late-stage clinical trial in a form of urothelial cancer, the Swiss drugmaker said on Friday.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
More News: Allergy | Allergy & Immunology | Cancer | Cancer & Oncology | Clinical Trials | Hematology | Immunotherapy | Switzerland Health